VONISH 0.3 (Voglibose (0.3mg))

VONISH-0.3 TABLET is indicated for the management of type 2 diabetes mellitus. This medication assists in regulating elevated blood sugar levels experienced after meals. It is particularly utilized when other comparable medications and a restricted dietary plan have not achieved sufficient control over high blood sugar levels. Administration should occur just prior to mealtime, and the specific dosage, as well as the frequency of intake, will be determined by your healthcare provider to ensure optimal blood sugar regulation. It is important to avoid abrupt cessation of the medication without consulting a healthcare professional, as this may lead to an increase in blood sugar levels, potentially resulting in serious complications such as kidney impairment and vision loss. This medication should be integrated into a broader treatment strategy that includes a nutritious diet, consistent physical activity, and weight management as per medical advice. Regular monitoring of blood sugar levels is essential while using this treatment. Some typical adverse reactions associated with VONISH-0.3 TABLET may include gas, abdominal discomfort, reduced appetite, constipation, and diarrhea. If any of these effects become persistent or troublesome, please consult your healthcare provider. Notably, VONISH-0.3 TABLET does not induce hypoglycemia when used alone; however, when combined with other antidiabetic medications, particularly insulin or sulfonylureas, it may increase the risk of low blood sugar events. Such occurrences can be managed by consuming plain glucose, as standard sugar may not be effective when on this treatment. Prior to initiating therapy, inform your healthcare provider about any existing kidney or liver conditions. This medication is contraindicated in patients with bowel ulcerations or inflammatory diseases, such as inflammatory bowel disease. Women who are pregnant or nursing should seek medical advice before starting this medication. It is also important to disclose all other medications being taken to ensure a safe treatment approach. Caution is advised regarding alcohol consumption, as it may heighten the risk of hypoglycemia while taking VONISH-0.3 TABLET.